SPL Medical starts clinical trials with Ferrotran

10 / 02 / 20

SPL Medical, situated on Novio Tech Campus in Nijmegen, starts an international registration-study for contrast dye Ferrotran. The research, which is to demonstrate the diagnostical power of the mean, will take place in ten hospitals in Germany, Suisse and the Netherlands (amongst which is the Radboudumc). 

SPL Medical starts clinical trials with Ferrotran

Blog
10 / 02 / 20

SPL Medical, situated on Novio Tech Campus in Nijmegen, starts an international registration-study for contrast dye Ferrotran. The research, which is to demonstrate the diagnostical power of the mean, will take place in ten hospitals in Germany, Suisse and the Netherlands (amongst which is the Radboudumc). 

Contrast dye Ferrotran, a product of Radboudumc spin-off SPL Medical, visualizes very small metastases in the lymph nodes on MRI. The dye even enables detection of micro-metastases (smaller than 2 millimetres). Other diagnostic techniques detect metastases no smaller than 4 to 6 millimetres.

 

Read full article (Dutch) on the website of Radboudumc.